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Abstract
Introduction: Although WHO declared the world moving into the post-pandemic period on August 10, 2010, influenza
A(H1N1) 2009 virus continued to circulate globally. Its impact was expected to continue during the 2010–11 influenza
season. This study describes the nationwide surveillance findings of the pandemic and post-pandemic influenza periods in
Taiwan and assesses the impact of influenza A(H1N1) 2009 during the post-pandemic period.
Methods: The Influenza Laboratory Surveillance Network consisted of 12 contract laboratories for collecting and testing
samples with acute respiratory tract infections. Surveillance of emergency room visits and outpatient department visits for
influenza-like illness (ILI) were conducted using the Real-Time Outbreak and Disease Surveillance system and the National
Health Insurance program data, respectively. Hospitalized cases with severe complications and deaths were reported to the
National Notifiable Disease Surveillance System.
Results: During the 2009–10 influenza season, pandemic A(H1N1) 2009 was the predominant circulating strain and caused
44 deaths. However, the 2010–11 influenza season began with A(H3N2) being the predominant circulating strain, changing
to A(H1N1) 2009 in December 2010. Emergency room and outpatient department ILI surveillance displayed similar trends.
By March 31, 2011, there were 1,751 cases of influenza with severe complications; 50.1% reported underlying diseases. Of
the reported cases, 128 deaths were associated with influenza. Among these, 93 (72.6%) were influenza A(H1N1) 2009 and
30 (23.4%) A(H3N2). Compared to the pandemic period, during the immediate post-pandemic period, increased number of
hospitalizations and deaths were observed, and the patients were consistently older.
Conclusions: Reemergence of influenza A(H1N1) 2009 during the 2010–11 influenza season had an intense activity with age
distribution shift. To further mitigate the impact of future influenza epidemics, Taiwan must continue its multifaceted
influenza surveillance systems, remain flexible with antiviral use policies, and revise the vaccine policies to include the
population most at risk.
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Introduction
Influenza pandemic (H1N1) 2009 virus emerged in April 2009
and quickly spread worldwide within 6 weeks. In Taiwan, the first
patient infected by the pandemic (H1N1) 2009 virus was identified
on 20 May, 2009. This strain of influenza soon became the
predominant subtype in circulation and caused 44 confirmed
deaths (the mortality rate was 1.9 deaths per million population) in
Taiwan during the 2009–10 influenza season. Although WHO
declared the world moving into the post-pandemic period on
August 10, 2010, the influenza A (H1N1) 2009 virus continued to
circulate globally. Its impact, severe complications in younger age
and high-risk groups, were expected to continue during the 2010–
11 influenza season [1,2].
Taiwan is situated in Eastern Asia with 23 million in population.
Since 1998, free influenza vaccines have been provided to targeted
groups such as the elderly, patients with catastrophic illnesses as
defined by the Bureau of National Health Insurance [3], health
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children. The annual vaccination coverage for seasonal influenza
in the entire population was around 10–15% in recent years.
Influenza surveillance in Taiwan includes the use of sentinel
physicians through the Influenza Laboratory Surveillance Net-
work, the Real-time Outbreak and Disease Surveillance (RODS),
National Health Insurance (NHI) data, and passive reporting of
influenza hospitalized cases with severe complications through the
National Notifiable Disease Surveillance System (NNDSS).
The Influenza Laboratory Surveillance Network is coordinated
by the Taiwan Centers for Disease Control (TCDC), and
comprises of 12 collaborating laboratories aimed to survey and
isolate viruses causing respiratory tract infections year round [4].
More than 275 sentinel physicians in private clinics or hospitals
voluntarily participated in this surveillance. The physicians were
distributed in 21 of the 22 administrative areas of Taiwan. Clinic-
and hospital-based physicians each contribute to approximately
50% of the specimens collected. The network has been in
operation since 1999.
RODS, developed by the University of Pittsburgh (Pittsburgh,
PA), was originally designed to detect bioterrorism events or
emerging diseases [5]. In Taiwan, RODS has been used to
monitor influenza activity through monitoring emergency room
(ER) visits [6]. There are more than 160 hospitals that participate
in RODS. For the surveillance of outpatient clinics, NHI database
is used. Of the 23 million people living in Taiwan, .99% are
enrolled in NHI [7], making NHI a comprehensive database to
monitor outpatient influenza activity.
According to the Communicable Disease Control Act, physi-
cians are required to report notifiable diseases within the allotted
time frame [8]. Influenza with severe complications was made
reportable to NNDSS in 2000 [9], requiring reporting within one
week. Otherwise, physicians may incur fines approximately USD
3,000–15,000. However, influenza with severe complications was
not widely reported until after the 2009 influenza pandemic. Prior
to the pandemic, approximately 15–35 confirmed cases were
reported in any given influenza season.
Through the use of all these surveillance methods, a nearly
complete picture of influenza activity nationwide emerges. This
study aimed to describe the nationwide influenza surveillance
findings of the pandemic (2009–10) and post-pandemic (2010–11)
periods in Taiwan, and to assess the impact of influenza A(H1N1)
2009 during the post-pandemic period.
Methods
Defining influenza seasons
Taiwan has a tropical-to-temperate spectrum of climatic zones.
The annual average temperature is 22uC with the lowest
temperatures ranging from 12uCt o1 7 uC. Winters are defined
as the months of December, January and February. In this study,
Taiwan’s influenza season was defined as July 1 to June 30 of the
following year. For the 2009–10 influenza season, this corre-
sponded to week 26, 2009–week 25, 2010; and for the study period
of the 2010–11 influenza season, this corresponded to week 26,
2010–week 13, 2011. Each year, influenza activity usually begins
to rise in late October, and peaks sometime during late December
to early February the following year.
Influenza Laboratory Surveillance
For the Influenza Laboratory Surveillance Network, clinical
specimens obtained from nasal or throat swabs were collected by
physicians and sent to TCDC collaborating laboratories for virus
isolation and identification using viral culture and/or reverse
transcriptase-polymerase chain reaction (RT-PCR). Methods of
virus isolation have been described previously [10]. Antigenic
characterization of the influenza virus was determined using the
hemagglutination inhibition (HI) assays with ferret antisera [11].
Oseltamivir-resistant influenza viruses were detected using DNA
sequencing and 50% inhibitory concentration (IC50) analysis of
neuraminidase activity [12].
Influenza-like Illness (ILI) Syndromic Surveillance
RODS collected individual patient’s International Classification of
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnostic
codes from patient ER visits, covering approximately 85% of all
ERs in Taiwan. ICD-9-CM codes were uploaded to RODS in real
time, making the data available for daily analysis. ILI cases were
detected using RODS predetermined set of ICD-9-CM codes for
respiratory syndrome [13].
For the NHIdatabase,allhealthcarefacilities(clinicsandhospitals)
submit outpatient department (OPD), ER, and inpatient ICD-9-CM
diagnostic codes to the Bureau of National Health Insurance (BNHI)
for reimbursement. Because BNHI provided financial incentives for
clinics and hospitals to submit good quality claims data electronically
within one day of each patient visit, the database had been reliablefor
insurance claims purposes. On weekdays, aggregated data in pre-
specified ICD-9-CM diagnostic code groups by age group and
geographic location were sent to TCDC electronically. ILI was
defined by ICD-9-CM codes 480–487.
Reporting of Influenza Cases with Severe Complications
and Deaths
For NNDSS, ILI in a patient who had any pulmonary
complications that required hospitalization, neurological compli-
cations, myocarditis or pericarditis, invasive bacterial infection, or
other severe conditions requiring intensive care unit admission
were reported and confirmed by RT-PCR or viral culture [6,14].
All laboratory-confirmed patients reported to NNDSS, with onset
dates during July 1, 2009–March 31, 2011, who met the case
definition, were included for analysis. In addition, for the 2010–11
influenza season we analyzed characteristics of confirmed patients
who died by the end of week 13, 2011, and influenza was
contributory as determined by a reviewing physician or recorded
on the death certificate. For patients who died, medical records,
where available, were reviewed.
Antiviral Prescriptions
Antiviral medications, including oseltamivir, zanamivir, and
peramivir, were provided free of charge by TCDC to 1) patients
with clinical evidence of severe influenza with complications; 2)
ILI patients with danger signs that signal progression to severe
disease [15]; 3) ILI patients with critical illness, chronic
cardiopulmonary disease, liver disease, renal disease, or diabetes
mellitus; 4) ILI patients with body mass index (BMI)$35; and 5)
ILI patients in an influenza outbreak. On January 25, 2011, free
antivirals were additionally provided to patients with fever for
$48 hours and ILI patients who had been in close contact with
other ILI patients at home, school, or workplace. Each
prescription was registered at the Countermeasure Management
Information System operated by TCDC. We compared the weekly
number of antiviral prescriptions with the number of ILI visits in
RODS from week 1, 2010 through week 13, 2011.
Comparing 2009–10 and 2010–11 Influenza Seasons
We compared the age distribution of influenza outpatient visits
(ICD-9-CM code 487) and influenza A(H1N1) 2009 cases with
2009–11 Nationwide Flu Surveillance in Taiwan
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11 influenza seasons. Chi-square tests were used to test whether
the two groups of patients were similar in age distribution.
Ethics
Data obtained for this study was for surveillance purposes;
therefore, this study was not reviewed by an institutional review
board.
Statistical methods
We used Microsoft Excel (2007) to produce figures and calculate
descriptive statistics such as counts and percentages. The chi-
square test, median and interquartile range (IQR) were performed
using SAS (SAS Institute Inc., Cary, NC, USA), Version 9.2 of the
SAS System for Windows 7.
Results
Responses during Pandemic and Post-pandemic Phases
To mitigate the effects of pandemic (H1N1) 2009 during the
pandemic period, Taiwan established the Central Epidemic
Command Center (CECC) to coordinate the use of resources
and implement control measures on April 28, 2009. During
November 1, 2009–April 3, 2010, 22.4% of the population
received at least one dose of the pandemic (H1N1) 2009 vaccine,
including 29.3% of persons aged 6 months to 6 years, 71.7% of
persons aged 7–18 years, and 11.3% of persons aged $19 years. A
total of 5.67 million doses were provided [16]. In addition to
providing the pandemic (H1N1) 2009 monovalent vaccine, rapid
influenza diagnostic tests and antiviral prescriptions were provided
through NHI from August 15, 2009 to March 31, 2010 [17].
During the post-pandemic phase, TCDC provided stockpiled
antivirals free of charge to contract clinics and hospitals for
patients meeting the five specified indications. During the 2010–11
influenza season, 12.3% of the population received at least one
dose of seasonal influenza vaccine, including 25.9% of persons
aged 6 months–6 years, 64.4% of children in grades 1–6 (aged 7–
12 years), and 37.3% of persons aged $65 years. For the 2010–11
influenza season, because of increasing ER visits, hospitalizations,
and deaths associated with influenza A(H1N1) 2009 during the
first three weeks of 2011 and only ERs of major hospitals remained
on duty during the week-long holiday in week 5 (the Lunar New
Year), TCDC relaxed the indications for antiviral prescriptions
from week 4 to week 13, 2011.
Virologic Surveillance
During the 2009–10 influenza season, there were 14,788
specimens tested. Of these, 3,970 (26.9%) were positive for
influenza viruses using viral culture and/or RT-PCR. Among the
positive specimens, there were 3,165 (79.7%) influenza
A(H1N1)2009, 545 (13.7%) influenza B, 216 (5.4%) influenza
A(H3N2), and 10 (0.3%) seasonal influenza A(H1N1). In
comparison, during the 2010–11 influenza season, influenza
A(H3N2) increased. During this period, 11,813 specimens were
tested. Of these, 2,767 (23.4%) were positive for influenza viruses
using viral culture and/or RT-PCR. Among the positive
specimens, there were 1,264 (45.7%) influenza A(H1N1)2009,
1,010 (36.5%) influenza A(H3N2), and 489 (17.7%) influenza B.
No seasonal A(H1N1) were found.
During the 2009–10 influenza season, the activity of influenza
A(H1N1) 2009 virus presented one peak in week 48 according to
the influenza positive rate. Influenza activity reached nadir in
week 7, 2010 (Fig. 1). Influenza A(H1N1) 2009 virus became the
predominant circulating strain in week 49 of the 2010–11
influenza season. Other circulating strains during this time
included influenza B and A(H3N2).
During the 2009–2011 study period, of the 146 influenza
A(H1N1) 2009 viruses tested using the hemagglutination inhibi-
tion (HI) assays, 142 (97.3%) were antigenically similar to the
vaccine strain, A/California/7/2009. All others showed reduced
Figure 1. Respiratory specimen testing influenza positive rates in Taiwan, week 26, 2009–week 13, 2011.
doi:10.1371/journal.pone.0036120.g001
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tested positive for mutation H275Y in the neuraminidase gene,
conferring resistance to oseltamivir. Epidemiologic investigations
indicated no clustering. No transmission was found after screening
of suspected cases with temporal association or in geographic
proximity.
Emergency and Outpatient Illness Surveillance
Following the first documented case of influenza A(H1N1)2009
was imported into Taiwan, patients seeking care for ILI at ERs
quickly rose, peaking in week 37, 2009. OPD surveillance had its
peak in week 48. This was followed by a much smaller rise during
week 7, 2010, occurring in both ER and OPD surveillance
because it was during the Lunar New Year, when the majority of
the private clinics were closed. While these clinics were closed,
patients with ILI sought help at ERs, resulting in the rise in ER
surveillance. For OPD surveillance, because patients with chronic
diseases stayed away during this period, the relative increase of ILI
patients resulted in the small rise.
For the 2010–11 influenza season, during week 47, 2010, the
percentage of ER patient-visits for ILI found through RODS
increased to 9.8% and continued to increase, reaching a peak of
26.0% during week 5, 2011. The trend in OPD visits was similar.
The percentage of OPD visits for ILI found through NHI
increased to 1.1% during week 48, 2010 and peaked at 2.4%
during week 5, 2011. This trend was similar to Taiwan’s usual
influenza seasons. For 2009–2010 influenza seasons, the peak
percentage of ILI in ER visits was 20.8% (week 37, 2009); OPD
visits was 2.7% (week 48, 2009) (Fig. 2).
Hospitalized Cases with Severe Complications and
Deaths
During the 2009–2010 influenza season, there were 1,297
hospitalized cases with severe complications reported to the
NNDSS. Among those, there were 937 (72.2%) patients infected
by influenza A(H1N1) 2009 virus, 161 (12.4%) by H3N2, 111
(8.6%) by A unsubtyped, 82 (6.3%) by influenza B, and 6 (0.5%)
by seasonal A(H1N1). For the 2010–11 influenza season, as of
week 13, 2011, there were 1,751 hospitalized cases with severe
complications reported (Fig. 3). Of the 1,751 cases reported, there
were 1,040 (59.4%) patients infected by influenza A(H1N1) 2009
virus, 606 (34.6%) by H3N2, 55 (3.1%) by A unsubtyped, and 50
(2.9%) by influenza B. During weeks 26–52, 2010, influenza
A(H3N2) caused disease in 548 (80.0%) of the 685 patients. In
contrast, influenza A(H1N1) 2009 caused disease in 932 (87.4%) of
the 1,066 patients with disease onset after January 1, 2011.
The incidence of hospitalized cases with severe complications
was highest among persons aged .64 years (21.4 per 100,000
population) during the 2010–11 influenza season (Fig. 4). The
peak of hospitalizations occurred in week 4 of 2011. The median
age of patients was 53.2 years (IQR, 31.9–70.2); 982 (56.1%) were
male. There were 878 (50.1%) patients with underlying diseases,
most commonly: 294 (16.8%) with metabolic diseases, 227 (13.0%)
cardiovascular diseases other than hypertension, and 227 (13.0%)
respiratory diseases. Admission to intensive care unit (ICU) was
required for 620 (35.4%) patients.
Of the 169 (9.7%) patients who died during the 2010–11
influenza season, 128 were directly or indirectly associated with
influenza (the mortality rate was 5.5 deaths per million
population). By week 50, 2010, deaths were predominantly caused
by H3N2 (Fig. 5). After week 51, deaths caused by influenza
A(H1N1) 2009 became predominant. Deaths peaked during weeks
3–5 of 2011. Among the 128 influenza-associated deaths, 93
(72.7%) were caused by influenza A(H1N1) 2009, 30 (23.4%) by
H3N2, 3 (2.3%) A unsubtyped, and 2 (1.6%) by influenza B. The
median age of those who died was 56.7 years (IQR, 49.9–68.5); 89
(69.5%) were male. There were 104 (81.3%) patients who received
antivirals, 41 (32.0%) within two days of symptom onset. Among
those who died, 110 (85.9%) had underlying diseases. Most
common underlying diseases reported were metabolic diseases
(39.1%), especially diabetes mellitus (25.8%). Of the 125 patients
with all dates available, on average, patients died 15 days after
symptom onset (median, 12 days; IQR, 6–22 days). Among the
deaths, only 2.3% of the patients received either the pandemic
(H1N1) 2009 monovalent vaccine or the 2010–11 seasonal
influenza vaccine.
Antiviral prescriptions
During the post-pandemic phase, although TCDC provided
free antivirals, the weekly antiviral prescriptions rarely exceeded
150 courses in 2010. After free antiviral use was relaxed in week 4,
2011, TCDC deployed 50,000 courses of antivirals to the 500
contract clinics and hospitals on January 25 (Tuesday of week 4),
2011. The numbers of antiviral prescriptions increased from 597
in week 3, to 4,055 in week 4, and to .11,000 in both weeks 5 and
6. A total of 69,866 antiviral prescriptions (oseltamivir accounted
for more than 98%) were given during week 26, 2010–week 13,
2011. Of these, 61.9% were prescribed during weeks 4–8, 2011,
the period when RODS showed the highest percentage of ILI
patient visits to ERs.
Comparing 2009–10 and 2010–11 Influenza Seasons
Comparison of the age distribution of influenza patients in the
2009–10 and 2010–11 influenza seasons showed that for all
disease spectrum of influenza A(H1N1) 2009 infections, patients
during the 2010–11 season were consistently older than the ones
during the 2009–10 season (Tables 1 and 2). All three Chi-square
tests for the differences in the age distribution between the two
groups were statistically significant with p,0.0001.
Discussion
Taiwan experienced influenza pandemic (H1N1) 2009 during
the pandemic phase and 5.67 million doses of pandemic (H1N1)
2009 monovalent vaccine were provided from November 1, 2009
to March 31, 2010 to Taiwan’s 23 million people. It is estimated
that over 22.4% of the population received at least one dose of the
pandemic (H1N1) 2009 vaccine in 2009 [16]. Despite the fact that
the virus showed no antigenic changes during the 2010–11 season
and very few drug resistance, a large epidemic of the same virus
recurred during the 2010–2011 influenza season.
However, population affected by the virus shifted to those who
were older. This age distribution shift in the post-pandemic period
is probably the result of predominantly school-aged children being
infected in 2009 and the effect of the Nationwide In-school
Influenza Vaccination in 2009 [18] and the 2010–11 season. The
one-dose coverage rate of the 2009 pandemic monovalent vaccine
for the 3.7 million students aged 7–18 years was 71.7%. Because
the most intensive influenza infections and vaccination efforts both
occurred among school-aged children in 2009, this age group most
likely was protected during the 2010–11 influenza season. For
children aged 7–12 years, 64.4% received the 2010–11 seasonal
influenza vaccines, further protecting them from influenza
A(H1N1) 2009 infections. In contrast, persons aged 20–64 years
and those with higher risk for influenza complications became the
most vulnerable groups during the 2010–11 season. The same
situation was also found in the United Kingdom, where persons
aged 15–44 years and at risk groups were the major groups
2009–11 Nationwide Flu Surveillance in Taiwan
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when influenza A(H1N1) 2009 was the predominant circulating
strain [19].
Among persons who died in association with influenza, 85.9%
had underlying diseases, mainly diabetes mellitus and cardiovas-
cular diseases other than hypertension. However, these persons
with high-risk underlying diseases were not targeted under the
current vaccination program; instead, persons with the 29 groups
of diseases listed as ‘‘catastrophic illnesses’’ in the NHI program
were [3]. Because vaccination is provided free of charge, TCDC
has yet to develop a good method to readily verify a person’s
disease status with known high-risk underlying diseases at
vaccination sites. Therefore, persons in high-risk groups not
marked for having a ‘‘catastrophic illness’’ were not included
among the vaccination target groups. Countries such as the United
States [20], Australia [21], and the United Kingdom [22] have
targeted persons with chronic illnesses, including those with
diabetes mellitus, cardiovascular diseases, and chronic respiratory
Figure 2. Percentages of influenza-like illness (ILI) visits in emergency room (ER) and outpatient department (OPD), week 26, 2009–
week 25, 2011.
doi:10.1371/journal.pone.0036120.g002
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consider similar measures to enroll all high-risk persons into future
seasonal influenza vaccination program.
During these two influenza seasons, because of the pandemic
and the subsequent severe influenza seasons, TCDC changed or
relaxed the indications for free antiviral use on a few occasions. It
is unclear how much impact relaxing antiviral prescriptions had on
mitigating the peak of influenza A(H1N1) 2009; however, having
reliable real-time influenza surveillance systems routinely in use
helped us to make a timely decision.
Why, then, did the large epidemic of influenza A(H1N1) 2009
with antigenicity similar to the 2009 pandemic monovalent
Figure 3. Number of influenza hospitalized cases with severe complications by week of onset in Taiwan, week 26, 2009–week 13,
2011.
doi:10.1371/journal.pone.0036120.g003
Figure 4. Incidence of influenza hospitalized cases with severe complications stratified by age and virus subtype in Taiwan, week
26, 2010–week 13, 2011.
doi:10.1371/journal.pone.0036120.g004
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Taiwan after week 50 of 2010? We postulate that at least three
factors played key roles for this phenomenon. First, the antibody
against influenza A(H1N1) 2009 acquired by natural infections or
vaccination may have decreased. Wang et al reported that at least
50% of the vaccinees and recovered patients lost sufficient
immunity after 6 months [23]. The declining herd immunity
may have resulted in the severe A(H1N1) 2009 epidemic. Second,
the A/Perth/16/2009 (H3N2)-like virus was the predominant
circulating virus during the first half of the 2010–11 influenza
season. Although influenza A(H3N2) virus did not circulate during
the typical influenza season, this virus also caused patient illness,
hospitalizations, and even deaths. Starting October 1, 2010, free
trivalent seasonal influenza vaccines (which include the circulating
H3N2 strain) were provided to target groups. The further decline
of H3N2 in November and December 2010 provided an
opportunity for influenza A(H1N1) 2009 to become the predom-
inant virus later. Third, Taiwan had a record-breaking cold winter
in 2010–2011. After the first cold front reached Taiwan on
December 16, 2010, the temperature remained relatively low.
According to the Taiwan Central Weather Bureau, the average
temperature for January 2011 was 13.7uC (56.7uF) in Taipei and
17.5uC (63.5uF) in Kaohsiung, representing the north and south,
respectively, making it the coldest January since 1972 [24]. On
average, the temperature in January 2011 was 2uC lower than the
average of the last 30 years. Because transmission of influenza
virus is highly dependent on temperature, unprecedented low
Figure 5. Number of influenza-associated deaths by week of onset in Taiwan, week 26, 2010–week 13, 2011.
doi:10.1371/journal.pone.0036120.g005
Table 1. Comparisons of numbers of influenza A(H1N1) 2009-
associated outpatient department (OPD) visits between 2009–
10 and 2010–11 seasons (as of week 13, 2011)*.
Age group 2009–10 season 2010–11 season p value
n( % ) n( % )
0–4 years 191,865 (9.2) 121,342 (7.5) ,0.0001
5–19 years 789,373 (37.9) 397,346 (24.7)
20–49 years 653,680 (31.3) 641,696 (39.9)
50–64 years 263,010 (12.6) 274,343 (17.0)
$65 years 187,399 (9.0) 175,236 (10.9)
*2009–10 season: from week 26, 2009 to week 25, 2010; 2010–11 season: from
week 26, 2010 to week 13, 2011.
doi:10.1371/journal.pone.0036120.t001
Table 2. Comparisons of numbers of influenza A(H1N1) 2009
cases with severe complications and deaths between 2009–10
and 2010–11 seasons (as of March 31, 2011)*.
Characteristic 2009–10 season 2010–11 season p value
n( % ) n( % )
Severe complications ,0.0001
0–4 years 119 (12.7) 81 (7.8)
5–19 years 370 (39.4) 87 (8.4)
20–49 years 277 (29.5) 411 (39.5)
50–64 years 105 (11.2) 305 (29.3)
$65 years 68 (7.2) 156 (15.0)
Deaths ,0.0001
0–4 years 1 (2.3) 3 (3.2)
5–19 years 8 (18.2) 2 (2.2)
20–49 years 22 (50.0) 24 (25.8)
50–64 years 9 (20.5) 49 (52.7)
$65 years 4 (9.1) 15 (16.1)
*2009–10 season: from week 26, 2009 to week 25, 2010; 2010–11 season: from
week 26, 2010 to week 13, 2011.
doi:10.1371/journal.pone.0036120.t002
2009–11 Nationwide Flu Surveillance in Taiwan
PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e36120temperature in a country where most households have no indoor
heating might contribute to the large epidemic of influenza
A(H1N1) 2009 [25,26].
The mortality rate in Taiwan caused by influenza A (H1N1)
2009 during the post-pandemic season was higher than during the
pandemic season (5.5 vs. 1.9 deaths per million population,
p,0.0001). These two numbers were similar to the death risks of
influenza A (H1N1) 2009 in England during the second and the
first waves of pandemic in the 2009–10 season (5.4 vs. 1.6 deaths
per million population), respectively [27]. Both Taiwan and
England reported higher mortality rate during the second wave
compared to the first wave. Comparable or even more severe post-
pandemic period was observed in the same winter in the several
European countries [28], such as UK [19,29,30], Greece [31], and
Spain [32]. Multiple waves of pandemic influenza were also
reported in past pandemics [33].
The findings in this study had some limitations. First, the
number of influenza-associated hospitalizations and deaths may be
underdiagnosed or underreported because data were derived from
a passive surveillance system. Second, using chart review and
death certificate to determine whether influenza was contributory
to death was subject to misclassification bias. Third, to track ILI
activity, we used ICD-9-CM administrative data for syndromic
surveillance, which may have lower specificity [34] and coding
errors [35].
In conclusion, reemergence of influenza A(H1N1) 2009 during
Taiwan’s 2010–2011 influenza season had an intense activity with
age distribution shift, that during the 2010–11 influenza season,
influenza A(H1N1) 2009 patients of all severities were consistently
older than those during the 2009–10 season. Most patients with
severe disease or died did not receive the current season’s influenza
vaccine. To further mitigate the impact of future influenza
epidemics, Taiwan must continue its multifaceted influenza
surveillance systems, remain flexible with antiviral use policies,
and revise the vaccine policies to include the population most at
risk.
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